Anne-laure L. Sennesael
Namur, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
In vitro assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines.
Journal: Research and practice in thrombosis and haemostasis
Published: February 24, 2024
Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
Journal: Frontiers in cardiovascular medicine
Published: January 29, 2022
The Impact of Strong Inducers on Direct Oral Anticoagulant Levels.
Journal: The American journal of medicine
Published: June 12, 2021
Inappropriate low dosing of direct oral anticoagulants in older patients with non-valvular atrial fibrillation: Impact on plasma drug levels.
Journal: Thrombosis research
Published: December 16, 2020
Medication Counselling in Older Patients Prior to Hospital Discharge: A Systematic Review.
Journal: Drugs & aging
Published: July 10, 2020
Assessment of low plasma concentrations of apixaban in the periprocedural setting.
Journal: International journal of laboratory hematology
Published: December 13, 2019
Andexanet alfa for the reversal of factor Xa inhibitors.
Journal: Expert opinion on biological therapy
Published: April 13, 2019
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study.
Journal: Thrombosis journal
Published: June 04, 2018
Glucose-regulated protein of 94 kDa contributes to the development of an aggressive phenotype in breast cancer cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 08, 2018
Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines.
Journal: Scientific reports
Published: February 15, 2018
Last Updated: 09/26/2026